Portfolio Company Headlines


September 25, 2018

Austin, TX
Molecular Templates, Inc. Announces Closing of Public Offering of Common Stock and the Full Exercise of the Underwriters’ Option to Purchase Additional Shares

September 19, 2018

Austin, TX
Molecular Templates Announces Agreement with Takeda for the Joint Development of a Protein-Based Oncology Therapy

July 20, 2018

Marlborough, MA
Boston Scientific Announces Agreement to Acquire Claret Medical, Inc.

July 9, 2018

Franklin Lakes, NJ
BD Acquires TVA Medical to Advance Leadership in Solutions for Chronic Kidney Disease

March 30, 2018


Northwestern Memorial Hospital Surgeon First in Illinois to Repair Aortic Valve with Novel Ring

January 24, 2018

Marlborough, MA
Boston Scientific Announces Investment and Acquisition Option Agreement with Millipede, Inc.

January 22, 2018

San Francisco, CA
Lyric Pharma Granted FDA Fast Track Designation for Lead Product Ulimorelin for Enteral Feeding Intolerance (EFI)

October 23, 2017

Santa Rosa, CA
Claret Medical Closes $14.5 Million in Series C Financing to Extend Successful U.S. Launch of Sentinel Cerebral Protection System

August 2, 2017


Molecular Templates Completes Merger with Threshold Pharmaceuticals and Private Placements

June 16, 2017


Sentinel Cerebral Protection System Used Commercially by TAVR Centers of Excellence Nationwide

June 15, 2017


TVA Medical – Study Published In Prominent Journal Supports Use Of Innovative Endovascular Hemodialysis Access Technology

June 14, 2017


BioStable Science & Engineering Announces U.S. Pilot Launch and First Commercial Use of the HAART™ 300 Aortic Annuloplasty Device

June 5, 2017


Claret Medical Receives FDA Clearance to Market Sentinel Cerebral Protection System in the U.S.

May 12, 2017


Millipede Announces Successful First Use of the Iris Complete Annuloplasty Ring

March 24, 2017


Biostable Science & Engineering scores FDA nod for aortic valve repair device